Published in J Appl Physiol (1985) on September 08, 2011
Cancer, physical activity, and exercise. Compr Physiol (2012) 0.94
Physical activity in different periods of life, sedentary behavior, and the risk of ovarian cancer in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev (2013) 0.84
The effect of physical activity across the menstrual cycle on reproductive function. Ann Epidemiol (2013) 0.77
Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice. J Physiol (2015) 0.76
Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study. Menopause (2016) 0.75
Role of hormones and blood lipids in the pathogenesis of acne vulgaris in non-obese, non-hirsute females. Indian Dermatol Online J (2014) 0.75
Advantages of exercise in breast cancer patients and survivors in addition to its mitigating effect on chest wall pain. Curr Oncol (2013) 0.75
Effects of intensive training on menstrual function and certain serum hormones and peptides related to the female reproductive system. Medicine (Baltimore) (2017) 0.75
Exercise-induced biochemical changes and their potential influence on cancer: a scientific review. Br J Sports Med (2016) 0.75
Strength training effects on urinary steroid profile across the menstrual cycle in healthy women. Eur J Appl Physiol (2012) 0.75
Mammographic density and the risk and detection of breast cancer. N Engl J Med (2007) 14.32
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science (2003) 13.19
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med (2002) 7.84
Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J (1973) 6.93
Physical activity and the risk of breast cancer. N Engl J Med (1997) 5.85
Estrogen and the risk of breast cancer. N Engl J Med (2001) 4.39
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer (1994) 4.37
Physical activity and weight loss: does prescribing higher physical activity goals improve outcome? Am J Clin Nutr (2003) 3.71
The gross composition of the body. Adv Biol Med Phys (1956) 3.66
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65
Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 3.41
Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11
Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: a randomized trial. JAMA (1999) 2.93
Group- vs home-based exercise training in healthy older men and women. A community-based clinical trial. JAMA (1991) 2.58
Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2005) 2.53
The behavioral determinants of exercise: implications for physical activity interventions. Annu Rev Nutr (2000) 2.27
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol (2005) 2.11
Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol (1994) 2.01
High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab (1998) 1.77
Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol (2003) 1.66
A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev (1994) 1.64
Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem (1991) 1.64
Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.56
Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol (1987) 1.55
Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J Clin Oncol (2007) 1.54
Mammary developmental fate and breast cancer risk. Endocr Relat Cancer (2005) 1.53
A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev (2000) 1.50
A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst (2008) 1.48
Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med (1985) 1.47
Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab (2003) 1.47
Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.38
The mammogram that cried Wolfe. N Engl J Med (2007) 1.37
Modifiers of risk of hereditary breast cancer. Oncogene (2006) 1.34
Generalized equations for predicting functional capacity from treadmill performance. Am Heart J (1984) 1.33
Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab (2001) 1.30
Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2005) 1.26
Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer (2004) 1.21
Progesterone involvement in breast development and tumorigenesis--as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids (2003) 1.19
Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev (2004) 1.16
Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev (1996) 1.14
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol (2002) 1.12
Menstrual disturbances in athletes: a focus on luteal phase defects. Med Sci Sports Exerc (2003) 1.12
Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev (1994) 1.11
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer (2006) 1.10
Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer (2007) 1.07
Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem (2003) 1.06
Physical activity and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort. Int J Cancer (2006) 1.04
Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology (2001) 1.01
Physical activity and ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2009) 1.00
Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev (1999) 1.00
Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer (2009) 0.99
Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1997) 0.98
Energy availability, not body fatness, regulates reproductive function in women. Exerc Sport Sci Rev (2003) 0.98
Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab (1991) 0.97
Pre-diagnosis physical activity and mammographic density in breast cancer survivors. Breast Cancer Res Treat (2005) 0.96
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2005) 0.95
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer (2002) 0.91
Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations. Clin Chem (1994) 0.88
Barriers and motivators for strength training among women of color and Caucasian women. Women Health (2008) 0.86
Does the dipstick meet medical needs for urine specific gravity? J Fam Pract (1987) 0.84
Bone density and cyclic ovarian function in trained runners and active controls. Med Sci Sports Exerc (1996) 0.82
Clinical management of BRCA1 and BRCA2 mutation carriers. Nat Clin Pract Oncol (2006) 0.81
Prophylactic bilateral mastectomy: patterns of practice. Cancer (2002) 0.81
Simultaneous assay of alpha-fetoprotein and free beta subunit of human chorionic gonadotropin by dual-label time-resolved immunofluorometric assay. Clin Chem (1993) 0.80
Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics. Ann Oncol (2004) 0.80
Lessons from experimental disruptions of the menstrual cycle in humans and monkeys. Med Sci Sports Exerc (2003) 0.79
Intrasubject variation of creatinine and specific gravity measurements in consecutive urine specimens of heroin users. Clin Chem (1995) 0.76
Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc (2000) 39.79
Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA (1995) 2.50
Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update (2009) 1.99
Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry (1993) 1.38
Effects of aerobic exercise training on cognitive function and cortical vascularity in monkeys. Neuroscience (2010) 1.26
Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab (1999) 1.24
Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab (1999) 1.24
Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J Clin Endocrinol Metab (2004) 1.21
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res Treat (2010) 1.19
Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr (2000) 1.18
Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond) (2007) 1.16
Comparison of the validity of anthropometric and bioelectric impedance equations to assess body composition in adolescent girls. Int J Body Compos Res (2007) 1.16
High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Hum Reprod (2009) 1.12
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol (1994) 1.11
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence. Breast Cancer Res Treat (2009) 1.10
Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab (2000) 1.09
Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.08
Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev (1998) 1.06
Menstrual cycle and basal metabolic rate in women. Am J Clin Nutr (1982) 1.03
Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr (2001) 1.02
Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer (1997) 1.02
Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2000) 1.01
The role of exercise in the prevention and treatment of osteoporosis and osteoarthritis. Nurs Clin North Am (2000) 1.01
Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology (2010) 0.97
Effect of the menstrual cycle on energy and nutrient intake. Am J Clin Nutr (1994) 0.96
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet (2010) 0.94
Role of the genetic counselor in familial cancer. Oncology (Williston Park) (1996) 0.94
Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial. Public Health Genomics (2010) 0.92
Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr (2007) 0.92
Reproducibility over time of measurements of androgens, estrogens and hydroxy estrogens in urine samples from post-menopausal women. Eur J Epidemiol (2003) 0.91
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2009) 0.90
Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol (1993) 0.90
Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab (1993) 0.90
Lack of effect of isoflavonic phytoestrogen intake on leptin concentrations in premenopausal and postmenopausal women. Fertil Steril (2001) 0.90
Acute effects of moderate intensity resistance exercise on bone cell activity. Int J Sports Med (2004) 0.89
Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancer. Ann Oncol (2005) 0.86
Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr (2007) 0.86
Sex ratio skewing of offspring in families with hereditary susceptibility to breast cancer. J Med Genet (2005) 0.86
Menstrual cycle effects on urinary estrogen metabolites. J Clin Endocrinol Metab (1999) 0.85
Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer (1998) 0.84
Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers. J Med Genet (2004) 0.83
Comprehensive 4-year follow-up on a case of maternal heterodisomy for chromosome 16. Am J Med Genet (1996) 0.83
Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr (1994) 0.83
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer (2009) 0.82
Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr (2004) 0.82
Meal energy content is related to features of meal-related ghrelin profiles across a typical day of eating in non-obese premenopausal women. Horm Metab Res (2006) 0.82
Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Fam Cancer (2012) 0.81
Isotope dilution gas chromatographic-mass spectrometric method for the determination of unconjugated lignans and isoflavonoids in human feces, with preliminary results in omnivorous and vegetarian women. Anal Biochem (1995) 0.81
Characterization of two novel BRCA1 germ-line mutations involving splice donor sites. Genet Test (2004) 0.80
Non-weightbearing exercise may increase lumbar spine bone mineral density in healthy postmenopausal women. Am J Phys Med Rehabil (1993) 0.79
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Br J Cancer (2011) 0.79
Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy. Fam Cancer (2008) 0.79
Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women. Bone (2011) 0.78
The relationship of natural killer cell counts, perforin mRNA and CD2 expression to post-exercise natural killer cell activity in humans. Acta Physiol Scand (2002) 0.78
Effects of energy deprivation on sex hormone patterns in healthy menstruating women. Am J Physiol (1986) 0.77
Effect of the menstrual cycle on creatinine clearance in normally cycling women. Obstet Gynecol (1998) 0.77
Circulating leptin concentrations do not distinguish menstrual status in exercising women. Hum Reprod (2011) 0.77
Nitrate and nitrogen balances in men. Am J Clin Nutr (1981) 0.76
Menstrual cycle and protein requirements of women. J Nutr (1982) 0.76
Effect of 12 weeks' light-moderate underfeeding on 24-hour energy expenditure in normal male and female subjects. Eur J Clin Nutr (1988) 0.76
The isolation and biochemical characterization of three subfractions of myelin from central nervous tissue of the adult rat. J Neurochem (1972) 0.75
Correction of misinterpretations and misrepresentations of the female athlete triad. Br J Sports Med (2007) 0.75
Energy expenditure during sleep in men and women: evaporative and sensible heat losses. Hum Nutr Clin Nutr (1987) 0.75
Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain. J Neurosurg (1991) 0.75
Sex steroid-binding protein in nonendocrine diseases. Ann N Y Acad Sci (1988) 0.75
Changes in body consciousness relate to regularity of exercise training. Percept Mot Skills (1992) 0.75
[The atraumatic system]. Zahnarztl Welt Zahnarztl Rundsch ZWR Zahnarztl Reform (1966) 0.75
Proteolipid protein: synthesis and assembly into quaking mouse myelin. J Neurochem (1979) 0.75
Postprandial peptide YY is lower in young college-aged women with high dietary cognitive restraint. Physiol Behav (2013) 0.75
Complexities in Cancer Risk Counseling: Presentation of Three Cases. J Genet Couns (1997) 0.75